Block & Leviton is actively litigating this case against Biogen and its executives concerning its representations about its new drug to treat Alzheimer's disease, Aduhelm. An amended complaint is due to be filed in June 2022, and the Court has already set a trial date for September 2023.
Contact our attorneys for a no-cost case evaluation.